Cargando…

Aging and Down Syndrome

Detalles Bibliográficos
Autores principales:	Head, Elizabeth, Silverman, Wayne, Patterson, David, Lott, Ira T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400297/ https://www.ncbi.nlm.nih.gov/pubmed/22844278 http://dx.doi.org/10.1155/2012/412536

Ejemplares similares

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review
por: Hamburg, Sarah, et al.
Publicado: (2019)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Cognitive and Behavioral Domains That Reliably Differentiate Normal Aging and Dementia in Down Syndrome
por: Harp, Jordan P., et al.
Publicado: (2021)

Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome
por: Martini, Alessandra C., et al.
Publicado: (2020)

Alzheimer's risk and quality of life: History of Down syndrome as a case in point
por: Silverman, Wayne, et al.
Publicado: (2021)

Language skills as a predictor of cognitive decline in adults with Down syndrome
por: Pulsifer, Margaret B., et al.
Publicado: (2020)

Altered connectivity of the default mode network in cognitively stable adults with Down syndrome: “Accelerated aging” or a prelude to Alzheimer's disease?
por: Rosas, H. Diana, et al.
Publicado: (2021)

Brain amyloid and the transition to dementia in Down syndrome
por: Keator, David B., et al.
Publicado: (2020)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

Pathways linking pulse pressure to dementia in adults with Down syndrome
por: Rizvi, Batool, et al.
Publicado: (2023)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Joint‐label fusion brain atlases for dementia research in Down syndrome
por: Queder, Nazek, et al.
Publicado: (2022)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Research attitudes in families of individuals with Down syndrome: importance for clinical trials
por: Lott, Ira T., et al.
Publicado: (2022)

Postmortem Neocortical (3)H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease
por: Pivtoraiko, Violetta N., et al.
Publicado: (2021)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

Down syndrome: Distribution of brain amyloid in mild cognitive impairment
por: Keator, David B., et al.
Publicado: (2020)

Aging in Down Syndrome: Latest Clinical Advances and Prospects
por: Martini, Alessandra C., et al.
Publicado: (2021)

Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models. Brain Sci. 2021, 11, 1220
por: Hom, Christy L., et al.
Publicado: (2022)

Ophthalmic Disorders in Adults with Down Syndrome
por: Krinsky-McHale, Sharon J., et al.
Publicado: (2012)

The Use of Mouse Models for Understanding the Biology of Down Syndrome and Aging
por: Vacano, Guido N., et al.
Publicado: (2012)

Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis
por: Head, Elizabeth, et al.
Publicado: (2018)

Gastrointestinal disorders in Down syndrome
por: Holmes, Geoffrey
Publicado: (2014)

Individuals with Down Syndrome: Editorial
por: Lanfranchi, Silvia, et al.
Publicado: (2022)

A fibril-specific, conformation-dependent antibody recognizes a subset of Aβ plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain
por: Sarsoza, Floyd, et al.
Publicado: (2009)

Rapamycin slows down gut aging
por: Gaur, Uma, et al.
Publicado: (2016)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Incidence of down syndrome: Hypotheses and reality
por: Vundinti, Babu Rao, et al.
Publicado: (2011)

Targeting APP/AICD in Down syndrome
por: Guidi, Sandra, et al.
Publicado: (2017)

Sterol Lipid Metabolism in Down Syndrome Revisited: Down Syndrome Is Associated with a Selective Reduction in Serum Brassicasterol Levels
por: Tansley, Gavin, et al.
Publicado: (2012)

Molecule of the month: miRNA and Down's syndrome
por: Shapshak, Paul
Publicado: (2013)

Down Syndrome: Neuropsychological Phenotype across the Lifespan
por: Pulsifer, Margaret
Publicado: (2021)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome
por: Andrews, Elizabeth J., et al.
Publicado: (2022)

Longitudinal assessment of dementia measures in Down syndrome
por: Koehl, Lisa, et al.
Publicado: (2020)

Disorders of Gut-Brain Interaction in Children With Down Syndrome
por: Park, Ji Sook
Publicado: (2023)

Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?
por: Head, Elizabeth, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_huuhrtgcp9hpncf80nbijnvufb